REGN Historical PE Ratio image   This REGN PE ratio history page last updated 8/5/2022
REGN Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2022
8/3/2022
608.779.7739.0815.6
Q1 2022
5/4/2022
660.8611.4945.9614.4
Q4 2021
2/4/2022
622.9623.7294.886.6
Q3 2021
11/4/2021
647.6315.3761.4810.5
Q2 2021
8/5/2021
602.4725.80103.205.8
Q1 2021
5/6/2021
498.689.8939.5612.6
Q4 2020
2/5/2021
498.989.5338.1213.1
Q3 2020
11/5/2020
588.818.3633.4417.6
Q2 2020
8/5/2020
624.527.1628.6421.8
Q1 2020
5/5/2020
574.376.6026.4021.8
Q4 2019
2/6/2020
389.857.5030.0013.0
Q3 2019
11/5/2019
332.606.6726.6812.5
Q2 2019
8/6/2019
300.266.0424.1612.4
Q1 2019
5/7/2019
322.404.4517.8018.1
Q4 2018
2/6/2019
406.566.8427.3614.9
Q3 2018
11/6/2018
357.615.8723.4815.2
Q2 2018
8/2/2018
397.005.4521.8018.2
Q1 2018
5/3/2018
292.414.6718.6815.7
Q4 2017
2/8/2018
322.625.2320.9215.4
Q3 2017
11/8/2017
415.173.9915.9626.0
Q2 2017
8/3/2017
467.114.1716.6828.0
Q1 2017
5/4/2017
434.312.9211.6837.2
Q4 2016
2/9/2017
360.003.0412.1629.6
Q3 2016
11/4/2016
341.393.1312.5227.3
Q2 2016
8/4/2016
433.402.8211.2838.4
Q1 2016
5/5/2016
377.732.5710.2836.7
Q4 2015
2/9/2016
365.972.8311.3232.3
Q3 2015
11/4/2015
564.003.4713.8840.6
Q2 2015
8/4/2015
580.942.8911.5650.3
Q1 2015
5/7/2015
468.622.8811.5240.7
Q4 2014
2/10/2015
400.712.7911.1635.9
Q3 2014
11/4/2014
372.392.5210.0836.9
Q2 2014
8/5/2014
333.202.479.8833.7
Q1 2014
5/8/2014
281.202.269.0431.1
Q4 2013
2/11/2014
326.522.248.9636.4
Q3 2013
11/5/2013
302.322.409.6031.5
Q2 2013
8/6/2013
254.500.793.1680.5
Q1 2013
5/3/2013
266.161.787.1237.4
Q4 2012
2/14/2013
169.244.0816.3210.4
Q3 2012
10/25/2012
155.231.897.5620.5
Q2 2012
7/25/2012
128.840.903.6035.8
Q1 2012
5/1/2012
134.380.110.44305.4
REGN PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2022
8/3/2022
608.779.7760.3510.1
Q1 2022
5/4/2022
660.8611.4976.388.7
Q4 2021
2/4/2022
622.9623.7274.788.3
Q3 2021
11/4/2021
647.6315.3760.5910.7
Q2 2021
8/5/2021
602.4725.8053.5811.2
Q1 2021
5/6/2021
498.689.8934.9414.3
Q4 2020
2/5/2021
498.989.5331.6515.8
Q3 2020
11/5/2020
588.818.3629.6219.9
Q2 2020
8/5/2020
624.527.1627.9322.4
Q1 2020
5/5/2020
574.376.6026.8121.4
Q4 2019
2/6/2020
389.857.5024.6615.8
Q3 2019
11/5/2019
332.606.6724.0013.9
Q2 2019
8/6/2019
300.266.0423.2012.9
Q1 2019
5/7/2019
322.404.4522.6114.3
Q4 2018
2/6/2019
406.566.8422.8317.8
Q3 2018
11/6/2018
357.615.8721.2216.9
Q2 2018
8/2/2018
397.005.4519.3420.5
Q1 2018
5/3/2018
292.414.6718.0616.2
Q4 2017
2/8/2018
322.625.2316.3119.8
Q3 2017
11/8/2017
415.173.9914.1229.4
Q2 2017
8/3/2017
467.114.1713.2635.2
Q1 2017
5/4/2017
434.312.9211.9136.5
Q4 2016
2/9/2017
360.003.0411.5631.1
Q3 2016
11/4/2016
341.393.1311.3530.1
Q2 2016
8/4/2016
433.402.8211.6937.1
Q1 2016
5/5/2016
377.732.5711.7632.1
Q4 2015
2/9/2016
365.972.8312.0730.3
Q3 2015
11/4/2015
564.003.4712.0346.9
Q2 2015
8/4/2015
580.942.8911.0852.4
Q1 2015
5/7/2015
468.622.8810.6644.0
Q4 2014
2/10/2015
400.712.7910.0439.9
Q3 2014
11/4/2014
372.392.529.4939.2
Q2 2014
8/5/2014
333.202.479.3735.6
Q1 2014
5/8/2014
281.202.267.6936.6
Q4 2013
2/11/2014
326.522.247.2145.3
Q3 2013
11/5/2013
302.322.409.0533.4
Q2 2013
8/6/2013
254.500.798.5429.8
Q1 2013
5/3/2013
266.161.788.6530.8
Q4 2012
2/14/2013
169.244.086.9824.2
Q3 2012
10/25/2012
155.231.89NANA
Q2 2012
7/25/2012
128.840.90NANA
Q1 2012
5/1/2012
134.380.11NANA
Quotes delayed 20 minutes

Email EnvelopeFree REGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Regeneron Pharmaceuticals (REGN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

REPH PE Ratio History
REPL PE Ratio History
RETA PE Ratio History
RGEN PE Ratio History
RGLS PE Ratio History
RGNX PE Ratio History
RIGL PE Ratio History
RLAY PE Ratio History
RLMD PE Ratio History
RLYB PE Ratio History
How should the REGN historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Regeneron Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this REGN Historical PE Ratio page.

What is the average historical PE for REGN based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The REGN historical PE ratio using the annualized quarterly earnings method works out to 32.3.

What is the average historical PE for REGN based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The REGN historical PE ratio using the TTM earnings method works out to 25.9.

What is the average historical PE for REGN based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The REGN historical PE ratio using the annualized median TTM earnings method works out to 53.72.

On this page we presented the REGN Historical PE Ratio information for Regeneron Pharmaceuticals' stock. The average REGN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 32.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average REGN historical PE based on this TTM earnings result method is 25.9.

Let's now compare this REGN historical PE result, against the recent PE: when this page was posted on 8/4/2022, the most recent closing price for REGN had been 614.96, and the most recent quarterly earnings result, annualized, was 39.08. Meanwhile, the most recent TTM earnings summed to 60.35. From these numbers, we calculate the recent REGN PE on 8/4/2022 based on annualized quarterly EPS was 15.7. Based on REGN's history, that recent PE is low relative to the historical average, with the recent PE 51.4% lower than the historical average PE across our data set for Regeneron Pharmaceuticals. Looking at the recent REGN PE on 8/4/2022 based on TTM EPS, we calculate the ratio at 10.2. Based on REGN's history, that recent PE is low relative to the historical average, with the recent PE 60.6% lower than the average PE across our Regeneron Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting REGN historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for REGN, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for REGN, we start with the past four EPS numbers and we first sort them from lowest to highest: 9.77, 11.49, 15.37, and 23.72. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 11.49 and 15.37 — which gives us the median of 13.43. Basically the way to think about this 13.43 number is this: for the trailing four earnings reports, 13.43 marks the "middle ground" number where REGN has reported a value higher than 13.43 half the time, and has reported a value lower than 13.43 half the time. Annualizing that median value then gets us to 53.72/share, which we use as the denominator in our next PE calculation. With 614.96 as the numerator (as of 8/4/2022), the calculation is then 614.96 / 53.72 = 11.4 as the REGN PE ratio as of 8/4/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on REGN or any other given stock, valuation analysis for REGN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Regeneron Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for REGN. Thanks for visiting, and the next time you need to research REGN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: SEB Next Dividend Date, Top Ten Hedge Funds Holding FOCT, GLBY market cap history.

 

REGN Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.